Coscelli, Andrea and Shum, Matthew (2004) An empirical model of learning and patient spillovers in new drug entry. Journal of Econometrics, 122 (2). pp. 213-246. ISSN 0304-4076 http://resolver.caltech.edu/CaltechAUTHORS:COSje04
Restricted to Caltech community only
See Usage Policy.
Use this Persistent URL to link to this item: http://resolver.caltech.edu/CaltechAUTHORS:COSje04
We specify and estimate a diffusion model for the new molecule omeprazole into the anti-ulcer drug market. Our model is based on a Bayesian learning process whereby doctors update their beliefs about omeprazole’s quality relative to existing drugs after observing its effects on the patients that have been prescribed this drug. The model also accommodates informational spillovers and heterogeneity in informativeness across patients with different diagnoses. We obtain estimates of the learning process parameters using a novel panel data set tracking doctors’ complete prescription histories over a 3-year period.
|Additional Information:||Copyright © 2003 Elsevier. Accepted 3 September 2003. We thank Dr. Giuseppe Traversa and Roberto Da Cas at the Istituto Superiore di Sanita’ and IMS Italy for providing the data, and Tim Bresnahan, Costas Meghir, Fiona Scott Morton, Peter Reiss, and Frank Wolak for their suggestions. We acknowledge financial support from a European Commission TMR fellowship #ERBFMBICT972232 (Coscelli) and a Sloan Foundation dissertation fellowship (Shum). We are grateful to an associate editor and two anonymous referees for detailed comments on earlier drafts.|
|Subject Keywords:||Entry of innovative drugs; Barriers to entry; Structural diffusion models|
|Usage Policy:||No commercial reproduction, distribution, display or performance rights in this work are provided.|
|Deposited By:||Lindsay Cleary|
|Deposited On:||31 Oct 2008 17:19|
|Last Modified:||26 Dec 2012 10:29|
Repository Staff Only: item control page